You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

List of Excipients in API carisoprodol


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing carisoprodol

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
STAT RX USA LLC SOMA carisoprodol 16590-755 ALGINIC ACID
STAT RX USA LLC SOMA carisoprodol 16590-755 MAGNESIUM STEARATE
STAT RX USA LLC SOMA carisoprodol 16590-755 POTASSIUM SORBATE
STAT RX USA LLC SOMA carisoprodol 16590-755 TRIBASIC CALCIUM PHOSPHATE
Wallace Pharmaceuticals Inc CARISOPRODOL carisoprodol 51525-5901 ALGINIC ACID
Wallace Pharmaceuticals Inc CARISOPRODOL carisoprodol 51525-5901 MAGNESIUM STEARATE
Wallace Pharmaceuticals Inc CARISOPRODOL carisoprodol 51525-5901 POTASSIUM SORBATE
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Start Trial

Excipients in ANDA-approved (generic) drugs containing carisoprodol

Company Ingredient NDC Excipient
Hikma Pharmaceuticals USA Inc carisoprodol 0143-1176 CELLULOSE, MICROCRYSTALLINE
Hikma Pharmaceuticals USA Inc carisoprodol 0143-1176 LACTOSE MONOHYDRATE
Hikma Pharmaceuticals USA Inc carisoprodol 0143-1176 MAGNESIUM STEARATE
Hikma Pharmaceuticals USA Inc carisoprodol 0143-1176 METHYLCELLULOSE
Hikma Pharmaceuticals USA Inc carisoprodol 0143-1176 POVIDONE K30
Hikma Pharmaceuticals USA Inc carisoprodol 0143-1176 SILICON DIOXIDE
Hikma Pharmaceuticals USA Inc carisoprodol 0143-1176 SODIUM LAURYL SULFATE
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Start Trial

Detailed excipient profiles for carisoprodol

Excipient focus: ALGINIC ACID

Excipient focus: ANHYDROUS LACTOSE

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: COLLOIDAL SILICON DIOXIDE

Excipient focus: CROSCARMELLOSE SODIUM

Excipient focus: CROSPOVIDONE

Excipient focus: D&C RED NO. 30

Excipient focus: DOCUSATE SODIUM

Excipient focus: FD&C BLUE NO. 1

Excipient focus: FD&C YELLOW NO. 5

Excipient focus: HYDROGENATED COTTONSEED OIL

Excipient focus: HYDROXYPROPYL CELLULOSE

carisoprodol drug variants containing HYDROXYPROPYL CELLULOSE

Company Ingredient NDC
Blenheim Pharmacal, Inc. carisoprodol 10544-088
RxChange Co. carisoprodol 33358-064
A-S Medication Solutions carisoprodol 50090-3048
Ingenus Pharmaceuticals, LLC carisoprodol 50742-656
Lake Erie Medical DBA Quality Care Products LLC carisoprodol 55700-451
Direct_Rx carisoprodol 61919-768
NuCare Pharmaceuticals Inc carisoprodol 66267-043
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2910

Excipient focus: HYPROMELLOSES

carisoprodol drug variants containing HYPROMELLOSES

Company Ingredient NDC
Blenheim Pharmacal, Inc. carisoprodol 10544-033
Nostrum Laboratories Inc carisoprodol 29033-207
Lake Erie Medical DBA Quality Care Products LLC carisoprodol 49999-064
Physicians Total Care, Inc. carisoprodol 54868-0816
Dispensing Solutions, Inc. carisoprodol 55045-1433
Quality Care Products LLC carisoprodol 55700-836
Quality Care Products LLC carisoprodol 55700-907
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: LACTOSE

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: MAGNESIUM STEARATE

carisoprodol drug variants not containing MAGNESIUM STEARATE

Company Ingredient NDC
Medsource Pharmaceuticals carisoprodol 45865-233
A-S Medication Solutions carisoprodol 50090-5953
A-S Medication Solutions carisoprodol 50090-5955
Quality Care Products LLC carisoprodol 55700-954
Bryant Ranch Prepack carisoprodol 63629-2416
Sallus Laboratories LLC carisoprodol 69036-920
Oxford Pharmaceuticals, LLC carisoprodol 69584-111
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: METHYLCELLULOSE

Excipient focus: MICROCRYSTALLINE CELLULOSE 101

carisoprodol drug variants containing MICROCRYSTALLINE CELLULOSE 101

Company Ingredient NDC
Medsource Pharmaceuticals carisoprodol 45865-233
A-S Medication Solutions carisoprodol 50090-5953
A-S Medication Solutions carisoprodol 50090-5955
Quality Care Products LLC carisoprodol 55700-954
Bryant Ranch Prepack carisoprodol 63629-2416
Sallus Laboratories LLC carisoprodol 69036-920
Oxford Pharmaceuticals, LLC carisoprodol 69584-111
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

carisoprodol drug variants not containing MICROCRYSTALLINE CELLULOSE 101

Company Ingredient NDC
Hikma Pharmaceuticals USA Inc carisoprodol 0143-1176
Actavis Pharma Inc carisoprodol 0591-5513
Blenheim Pharmacal, Inc. carisoprodol 10544-033
Blenheim Pharmacal, Inc. carisoprodol 10544-088
Blenheim Pharmacal, Inc. carisoprodol 10544-132
Apotheca Inc carisoprodol 12634-437
Rising Pharma Holdings Inc carisoprodol 16571-780
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: POTASSIUM SORBATE

Excipient focus: POVIDONE

Excipient focus: POVIDONE K30

Excipient focus: POVIDONES

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM BENZOATE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

Excipient focus: STARCH, CORN

Excipient focus: STEARIC ACID

Excipient focus: TALC

Excipient focus: TRIBASIC CALCIUM PHOSPHATE

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
 NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links